Clinical trials recruiting for Rhinoconjunctivitis
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| 10,000 MG01 + 10,000 T517 | 1 |
| 10,000 MG01 +10,000 T521 | 1 |
| 10,000 MM09 | 1 |
| 30,000 MG01 + 10,000 T517 | 1 |
| 30,000 MG01 +10,000 T521 | 1 |
| 30,000 MM09 | 1 |
| Allergen Immunotherapy Extract | 1 |
Self-screener
Recruiting trials
- Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen
- Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites
- Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.
- Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df
Related conditions
Trials recruiting for Rhinoconjunctivitis often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Rhinoconjunctivitis trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.